MicroRNA as therapeutic targets for treatment of depression
Katelin F Hansen, Karl Obrietan Department of Neuroscience, Ohio State University, Columbus, OH, USA Abstract: Depression is a potentially life-threatening mental disorder affecting approximately 300 million people worldwide. Despite much effort, the molecular underpinnings of clinical depression re...
Guardado en:
Autores principales: | Hansen KF, Obrietan K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1bb88aba7dc5439c9db979159eaf320c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MicroRNA-Based Biomarkers in the Diagnosis and Monitoring of Therapeutic Response in Patients with Depression
por: Xu YY, et al.
Publicado: (2019) -
Diagnostic and therapeutic utility of neuroimaging in depression: an overview
por: Wise T, et al.
Publicado: (2014) -
MicroRNA-202-3p Targets Brain-Derived Neurotrophic Factor and Is Involved in Depression-Like Behaviors
por: Xin C, et al.
Publicado: (2020) -
Epidemiology and treatment of post-stroke depression
por: Stefano Paolucci
Publicado: (2008) -
Postpartum depression: psychoneuroimmunological underpinnings and treatment
por: Anderson G, et al.
Publicado: (2013)